Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens

Jie Gao,1–3 Lukasz J Ochyl,1,3 Ellen Yang,4 James J Moon1,3,5 1Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA; 2Department of Pharmaceutical Sciences, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China;...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gao J, Ochyl LJ, Yang E, Moon JJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/4770b51d056c4ae1982baf360e7fc0b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4770b51d056c4ae1982baf360e7fc0b0
record_format dspace
spelling oai:doaj.org-article:4770b51d056c4ae1982baf360e7fc0b02021-12-02T05:10:27ZCationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens1178-2013https://doaj.org/article/4770b51d056c4ae1982baf360e7fc0b02017-02-01T00:00:00Zhttps://www.dovepress.com/cationic-liposomes-promote-antigen-cross-presentation-in-dendritic-cel-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Jie Gao,1–3 Lukasz J Ochyl,1,3 Ellen Yang,4 James J Moon1,3,5 1Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA; 2Department of Pharmaceutical Sciences, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Biointerfaces Institute, 4Department of Chemistry, 5Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA Abstract: Cationic liposomes (CLs) have been widely examined as vaccine delivery nanoparticles since they can form complexes with biomacromolecules, promote delivery of antigens and adjuvant molecules to antigen-presenting cells (APCs), and mediate cellular uptake of vaccine components. CLs are also known to trigger antigen cross-presentation – the process by which APCs internalize extracellular protein antigens, degrade them into minimal CD8+ T-cell epitopes, and present them in the context of major histocompatibility complex-I (MHC-I). However, the precise mechanisms behind CL-mediated induction of cross-presentation and cross-priming of CD8+ T-cells remain to be elucidated. In this study, we have developed two distinct CL systems and examined their impact on the lysosomal pH in dendritic cells (DCs), antigen degradation, and presentation of peptide:MHC-I complexes to antigen-specific CD8+ T-cells. To achieve this, we have used 3β-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) as the prototypical components of CLs with tertiary amine groups and compared the effect of CLs and anionic liposomes on lysosomal pH, antigen degradation, and cross-presentation by DCs. Our results showed that CLs, but not anionic liposomes, elevated the lysosomal pH in DCs and reduced antigen degradation, thereby promoting cross-presentation and cross-priming of CD8+ T-cell responses. These studies shed new light on CL-mediated cross-presentation and suggest that intracellular fate of vaccine components and subsequent immunological responses can be controlled by rational design of nanomaterials. Keywords: cationic liposome, nanoparticle, vaccine, cross-presentation, lysosomeGao JOchyl LJYang EMoon JJDove Medical Pressarticlecationic liposomenanoparticlevaccinecross-presentationlysosomeMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 1251-1264 (2017)
institution DOAJ
collection DOAJ
language EN
topic cationic liposome
nanoparticle
vaccine
cross-presentation
lysosome
Medicine (General)
R5-920
spellingShingle cationic liposome
nanoparticle
vaccine
cross-presentation
lysosome
Medicine (General)
R5-920
Gao J
Ochyl LJ
Yang E
Moon JJ
Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
description Jie Gao,1–3 Lukasz J Ochyl,1,3 Ellen Yang,4 James J Moon1,3,5 1Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA; 2Department of Pharmaceutical Sciences, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Biointerfaces Institute, 4Department of Chemistry, 5Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA Abstract: Cationic liposomes (CLs) have been widely examined as vaccine delivery nanoparticles since they can form complexes with biomacromolecules, promote delivery of antigens and adjuvant molecules to antigen-presenting cells (APCs), and mediate cellular uptake of vaccine components. CLs are also known to trigger antigen cross-presentation – the process by which APCs internalize extracellular protein antigens, degrade them into minimal CD8+ T-cell epitopes, and present them in the context of major histocompatibility complex-I (MHC-I). However, the precise mechanisms behind CL-mediated induction of cross-presentation and cross-priming of CD8+ T-cells remain to be elucidated. In this study, we have developed two distinct CL systems and examined their impact on the lysosomal pH in dendritic cells (DCs), antigen degradation, and presentation of peptide:MHC-I complexes to antigen-specific CD8+ T-cells. To achieve this, we have used 3β-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) as the prototypical components of CLs with tertiary amine groups and compared the effect of CLs and anionic liposomes on lysosomal pH, antigen degradation, and cross-presentation by DCs. Our results showed that CLs, but not anionic liposomes, elevated the lysosomal pH in DCs and reduced antigen degradation, thereby promoting cross-presentation and cross-priming of CD8+ T-cell responses. These studies shed new light on CL-mediated cross-presentation and suggest that intracellular fate of vaccine components and subsequent immunological responses can be controlled by rational design of nanomaterials. Keywords: cationic liposome, nanoparticle, vaccine, cross-presentation, lysosome
format article
author Gao J
Ochyl LJ
Yang E
Moon JJ
author_facet Gao J
Ochyl LJ
Yang E
Moon JJ
author_sort Gao J
title Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
title_short Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
title_full Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
title_fullStr Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
title_full_unstemmed Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
title_sort cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal ph and limiting the degradation of antigens
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/4770b51d056c4ae1982baf360e7fc0b0
work_keys_str_mv AT gaoj cationicliposomespromoteantigencrosspresentationindendriticcellsbyalkalizingthelysosomalphandlimitingthedegradationofantigens
AT ochyllj cationicliposomespromoteantigencrosspresentationindendriticcellsbyalkalizingthelysosomalphandlimitingthedegradationofantigens
AT yange cationicliposomespromoteantigencrosspresentationindendriticcellsbyalkalizingthelysosomalphandlimitingthedegradationofantigens
AT moonjj cationicliposomespromoteantigencrosspresentationindendriticcellsbyalkalizingthelysosomalphandlimitingthedegradationofantigens
_version_ 1718400526627897344